Close
Help




JOURNAL

Clinical Medicine Insights: Case Reports

Cabergoline Treatment in Invasive Giant Prolactinoma

Submit a Paper


Clinical Medicine Insights: Case Reports 2014:7 49-51

Case report

Published on 19 Jun 2014

DOI: 10.4137/CCRep.S15790


Further metadata provided in PDF



Sign up for email alerts to receive notifications of new articles published in Clinical Medicine Insights: Case Reports

Abstract

Patients with invasive giant prolactinoma suffer from a constellation of symptoms including headache, blurred vision, lethargy, and sexual dysfunction. Cabergoline, a potent dopamine agonist, is a known medication prescribed for the treatment of invasive giant prolactinoma. Here, we report a case of invasive giant prolactinoma in a 52-year-old Saudi male with dramatic response to cabergoline treatment clinically, biochemically, and radiologically.



Downloads

PDF  (840.70 KB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)

XML

PMC HTML


Sharing


What Your Colleagues Say About Clinical Medicine Insights: Case Reports
The experience with the journal was excellent.  The submission process with simple, reviews were expedited quickly, and communication with the corresponding author was excellent.
Dr Andrew Briggs (Curtin University, Australia)
More Testimonials

Quick Links


New article and journal news notification services
Email Alerts RSS Feeds
Facebook Google+ Twitter
Pinterest Tumblr YouTube